Company news

Share this article:
Abbott Laboratories has announced plans to acquire Ibis Biosciences, the molecular diagnostics division of Isis Pharmaceuticals. Abbott invested $40 million in the company earlier this year, and will purchase all remaining equity for $175 million. 
 
Wyeth Pharmaceuticals has announced the acquisition of Thiakis Limitied, a privately held biotech based in the UK. Thiakis lead product candidate, TKS 1225, will potentially treat obesity and other co-morbidities. 
 
New England-based pharma research firm Charles River Laboratories will invest $20 million and create 60 jobs by expanding its Charleston, SC, operations.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.